Evidence map›Paper›PMID 29731246›Full record

ArticleSurgery2018

GDF11 induces kidney fibrosis, renal cell epithelial-to-mesenchymal transition, and kidney dysfunction and failure.

Marianne Pons, Leonidas G Koniaris, Sharon M Moe, Juan C Gutierrez, Aurora Esquela-Kerscher, Teresa A Zimmers

Open access · bronzeAbstract read
In one paragraph

Article in Surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. GDF11-secreting cell transplant efficiently ameliorates age-related pulmonary fibrosis.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Marianne PonsDepartment of Surgery, Indiana University School of Medicine, Indianapolis.
Leonidas G KoniarisDepartment of Surgery, Indiana University School of Medicine, Indianapolis. Electronic address: lkoniari@iu.edu.
Sharon M MoeDepartment of Medicine, Indiana University School of Medicine, Indianapolis; Roudebush Veterans Administration Medical Center, Indianapolis, IN.
Juan C GutierrezDepartment of Surgery, University of Miami School of Medicine.
Aurora Esquela-KerscherDepartment of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk.
Teresa A ZimmersDepartment of Surgery, Indiana University School of Medicine, Indianapolis; Departments of Anatomy and Cell Biology, Biochemistry and Molecular Biology and Otolaryngology-Head & Neck Surgery, Indiana University School of Medicine, Indianapolis; IU Simon Cancer Center, Indianapolis, IN.
Indiana University School of MedicineEastern Virginia Medical School · USIndiana University Health · USIndiana University – Purdue University Indianapolis · USUniversity of Miami · US

Funding

Myostatin Family Signaling in Burn-Injury Related Muscle WastingR01GM092758 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ZIMMERS, TERESA A · 2010 to 2014
$1.6M
PQB3: Mechanisms & Targeting of Sonic Hedgehog Signaling in Muscle Wasting of Cancer CachexiaR01CA194593 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI ZIMMERS, TERESA A · 2015 to 2018
$1.4M
EGFR therapies for fatty liver surgeryR01DK096167 · NIDDK · THOMAS JEFFERSON UNIVERSITY · PI KONIARIS, LEONIDAS G. · 2012 to 2014
$1.0M
NCI NIH HHS R01 CA194593NIDDK NIH HHS R01 DK096167NIGMS NIH HHS R01 GM092758
6 · The paper itself

Abstract

backgroundGDF11 modulates embryonic patterning and kidney organogenesis. Herein, we sought to define GDF11 function in the adult kidney and in renal diseases.

methodsIn vitro renal cell lines, genetic, and murine in vivo renal injury models were examined.

resultsAmong tissues tested, Gdf11 was highest in normal adult mouse kidney. Expression was increased acutely after 5/6 nephrectomy, ischemia-reperfusion injury, kanamycin toxicity, or unilateral ureteric obstruction. Systemic, high-dose GDF11 administration in adult mice led to renal failure, with accompanying kidney atrophy, interstitial fibrosis, epithelial-to-mesenchymal transition of renal tubular cells, and eventually death. These effects were associated with phosphorylation of SMAD2 and could be blocked by follistatin. In contrast, Gdf11 heterozygous mice showed reduced renal Gdf11 expression, renal fibrosis, and expression of fibrosis-associated genes both at baseline and after unilateral ureteric obstruction compared with wild-type littermates. The kidney-specific consequences of GDF11 dose modulation are direct effects on kidney cells. GDF11 induced proliferation and activation of NRK49f renal fibroblasts and also promoted epithelial-to-mesenchymal transition of IMCD-3 tubular epithelial cells in a SMAD3-dependent manner.

conclusionTaken together, these data suggest that GDF11 and its downstream signals are critical in vivo mediators of renal injury. These effects are through direct actions of GDF11 on renal tubular cells and fibroblasts. Thus, regulation of GDF11 presents a therapeutic target for diseases involving renal fibrosis and impaired tubular function.

Indexed as

Epithelial-Mesenchymal TransitionAnimalsBone Morphogenetic ProteinsCell LineFemaleFollistatinGrowth Differentiation FactorsKidneyMaleMice, Inbred C57BLMice, NudeNephrosclerosisRenal InsufficiencySmad2 ProteinBone Morphogenetic ProteinsFollistatinGdf11 protein, mouseGrowth Differentiation FactorsSmad2 ProteinSmad2 protein, mouse

Identifiers

PMID29731246
PMCPMC6056317
OpenAlexW2800236666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.